Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
34.81
+0.88 (2.59%)
At close: Jun 26, 2026, 4:00 PM EDT
35.51
+0.70 (2.01%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Beam Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Beam Therapeutics stock have an average target of 49.77, with a low estimate of 26 and a high estimate of 80. The average target predicts an increase of 42.98% from the current stock price of 34.81.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beam Therapeutics stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 14 | 14 | 14 | 14 | 14 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $70 | Buy | Maintains | $70 | +101.09% | Jun 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $75 | Buy | Maintains | $75 | +115.46% | May 21, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $80 | Buy | Reiterates | $80 | +129.82% | May 21, 2026 |
| Citi | Citi | Buy Maintains $68 | Buy | Maintains | $68 | +95.35% | May 14, 2026 |
| Bernstein | Bernstein | Buy Reiterates $40 → $39 | Buy | Reiterates | $40 → $39 | +12.04% | May 13, 2026 |
Financial Forecast
Revenue This Year
73.19M
from 139.74M
Decreased by -47.63%
Revenue Next Year
87.27M
from 73.19M
Increased by 19.25%
EPS This Year
-4.47
from -0.81
EPS Next Year
-4.74
from -4.47
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 136.8M | 226.4M | |
| Avg | 73.2M | 87.3M | |
| Low | 35.0M | 34.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.1% | 209.3% | |
| Avg | -47.6% | 19.2% | |
| Low | -75.0% | -53.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -4.47 | -4.74 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.